Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events-Reply.
Gage, Brian F
Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events-Reply. [electronic resource] - JAMA 03 2018 - 1279-1280 p. digital
Publication Type: Letter; Comment
1538-3598
10.1001/jama.2018.0195 doi
Algorithms
Anticoagulants
Cytochrome P-450 CYP2C9--genetics
Genotype
Humans
International Normalized Ratio
Pharmacogenetics
Warfarin
Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events-Reply. [electronic resource] - JAMA 03 2018 - 1279-1280 p. digital
Publication Type: Letter; Comment
1538-3598
10.1001/jama.2018.0195 doi
Algorithms
Anticoagulants
Cytochrome P-450 CYP2C9--genetics
Genotype
Humans
International Normalized Ratio
Pharmacogenetics
Warfarin